Plante Moran Financial Advisors, LLC Oramed Pharmaceuticals Inc. Transaction History

Plante Moran Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$1.93 - $13.1 $15,268 - $103,634	-7,911 Closed	0 $0
Q2 2022 Aug 02, 2022	BUY	$3.72 - $9.0 $1,231 - $2,979	331 Added 4.37%	7,911 $36,000
Q2 2021 Aug 10, 2021	BUY	$8.34 - $14.59 $63,217 - $110,592	7,580 New	7,580 $101,000
Q4 2017 Feb 01, 2018	SELL	$7.95 - $11.15 $2,385 - $3,345	-300 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$7.74 - $10.78 $2,322 - $3,234	300	300 $3,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.